LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single‐centre pilot study

Photo by atikahakhtar from unsplash

Recurrent or chronic erythema nodosum leprosum (ENL) is result of immunological reactions in leprosy resulting in significant morbidity and disability for the patients. It is a difficult condition to manage… Click to show full abstract

Recurrent or chronic erythema nodosum leprosum (ENL) is result of immunological reactions in leprosy resulting in significant morbidity and disability for the patients. It is a difficult condition to manage as patients require prolonged courses of high-dose prednisolone with risks of adverse effects (AEs), such as hypertension, diabetes or osteoporosis and steroid dependency along with immunosuppression.1 Steroid sparing agents like thalidomide,2 clofazimine, minocycline, cyclosporine, pentoxyfilline, azathioprine and methotrexate have been used with variable success rates.

Keywords: multibacillary leprosy; apremilast multibacillary; nodosum leprosum; erythema nodosum

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.